FIELD: medicine.
SUBSTANCE: invention relates to cosmetic industry, in particular to oral care agent. Oral composition intended for treatment, inhibition or mitigation of inflammatory condition in mouth cavity and containing Camellia extract and 2',4,4'-trichloro-2-hydroxydiphenyl ether. Application of composition for treatment, inhibition or mitigation of inflammatory condition of mouth cavity.
EFFECT: composition efficiently treats, inhibits or mitigates inflammatory condition of mouth cavity.
12 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS FOR ORAL CAVITY CARE, CONTAINING VEGETABLE EXTRACTS | 2008 |
|
RU2440821C2 |
ORAL COMPOSITIONS CONTAINING OXIDISED CAMELLIA | 2005 |
|
RU2390329C2 |
ORAL CARE COMPOSITIONS CONTAINING COMBINATIONS OF ANTIBACTERIAL AGENTS AND AGENTS CHANGING CARRIER BODY REACTION | 2007 |
|
RU2448711C2 |
ORAL CARE COMPOSITION CONTAINING MIXED TOCOPHEROL COMPONENT | 2008 |
|
RU2445949C2 |
COMPOSITIONS FOR ORAL CAVITY CONTAINING ROSMARINUS EXTRACTS AND ASSOCIATED METHODS | 2005 |
|
RU2388456C2 |
METHOD OF REDUCING INFLAMMATION OF ORAL CAVITY TISSUE WITH APPLICATION OF MAGNOLIA EXTRACT | 2005 |
|
RU2406522C2 |
COMPOSITIONS FOR ORAL CARE CONTAINING FLAVONOIDS AND FLAVANES | 2005 |
|
RU2393899C2 |
COMPOSITIONS FOR ORAL CAVITY CARE FROM OREGANO AND METHODS OF THEIR APPLICATION | 2005 |
|
RU2355384C2 |
THERAPEUTIC ORAL COMPOSITIONS | 2010 |
|
RU2535088C2 |
OXIDATION-RESISTANT DENTAL CARE COMPOSITIONS | 2005 |
|
RU2373922C2 |
Authors
Dates
2010-11-27—Published
2005-12-21—Filed